The National Community Pharmacists Association (NCPA) has proposed a variety of pro-patient and pro-pharmacist proposals to the U.S. Senate Finance Committee's Chronic Care Working Group. Read More »
Aetna announced this week that it will sign an accountable care organization agreement in accordance with the Delaware Valley Accountable Care Organization (DVACO). Read More »
MedNetOne Health Solutuions (MNOHS), which provides health-care management services, announced that it will be teaming up with Sav-Mor Drug Stores, based in Michigan. Read More »
The American Society of Health-System Pharmacists (ASHP) recently released its 2016 edition of the AHFS Drug Information (AHFS DI). Read More »
CVS Health announced this week that naloxone, an opioid overdose reversal medicine, would be made available in all CVS Pharmacies across Ohio and that a prescription would not be necessary for the purchase of the product. Read More »
Easton Pharmaceuticals, along with their partner, BMV Medica, announced this week that it has placed an initial order for the vaginal discharge diagnostic test, VS-Sense, and the amniotic fluid leak test, AmnioSense, from CommonSense, which manufactures the products in Israel. Read More »
ACADIA Pharmaceuticals announced last week that the Psychopharmacologic Drugs Advisory Committee, a committee that operates under the FDA, will review its New Drug Application (NDA) for NUPLAZID. Read More »
Bristol-Myers Squibb and Pfizer announced this week that the companies have agreed to a cooperative effort with Portola Pharmaceuticals to develop and commercialize andexanet alpha. Read More »
The American Journal of Pharmacy Benefits (AJPB) recently announced that it has officially launched its website, www.ajpb.com. Read More »
The U.S. Food and Drug Administration (FDA) has made a commitment to work on the backlogged list of generic drugs currently awaiting approval. Read More »
Merck announced this week that the Food and Drug Administration (FDA) has accepted its Biologics License Application for bezlotoxumab for review. Read More »
CVS Health Research Institute has released a study that shows substantial progress in specialty medication given to their patients who are enrolled in a pilot study that assesses Specialty Connect. Read More »
Pharmaceutical companies worldwide have joined together to appeal to governments to aid them in taking on what are called "superbugs." Read More »
AstraZeneca announced this week that its product Lynparza has been granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA). Read More »
EMD Serono announced this week that Gary Zieziula has been named president and managing director of the biopharma company. Read More »
The NACDS and its partner Healthcare Ready are coming to the aid of those needing medical supplies and prescriptions all along the East Coast, which was recently buried in snow and ice by Winter Storm Jonas. Read More »
The ASHP has published a new guide that will help determine the proper doses of medication for obese patients. Read More »
The Centers for Medicare and Medicaid Services (CMS) confirmed last week a rule to restructure Medicaid rebate and reimbursement programs for prescription drugs. Read More »
AstraZeneca has joined with GlaxoSmithKline and Johnson & Johnson to collaborate with three world-class universities to start the Apollo Therapeutics Fund. Read More »
Keystone Peer Review Organization Inc. (KEPRO) announced this week that it has agreed to its continued use of InterQual on a long-term basis. Read More »
Alerts Sign-up
